One-Year Outcomes of Remote Ex-Vivo Lung Perfusion in the Real-World Setting
Purpose: Ex vivo lung perfusion (EVLP) allows for evaluation of marginal donor lungs, but its widespread adoption is limited by lack of center expertise and logistical support for in-house EVLP. Clinical trials have demonstrated the feasibility of remote EVLP at a centralized facility to expand access to centers without in-house EVLP. The outcomes of remote EVLP outside of clinical trials are unclear due to scarcity and incomplete data. Our team will report on 1-year outcomes for the use of remote EVLP utilizing centralized lung evaluation system (CLES) via a third-party provider in a real world, non-clinical trial setting at two transplant centers (Mayo Clinic Florida (n=24) and Vanderbilt University (n=21)) from December 2, 2020, to March 20,2023.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: , C. Demarest, W.D. Tucker, B.S. Petree, J.W. Stokes, S.M. Pham, M. Thomas, M. Bacchetta, J. Mallea Source Type: research
More News: Cardiology | Clinical Trials | Heart | Heart Transplant | Lung Transplant | Perfusion | Transplant Surgery | Transplants